Oncolytics Biotech Incis A Clinical Stage Biopharmaceutical Company Based In Calgaryalbertacanadathe Company Is Dedicated To Developing Innovative Immunotherapies For Cancer Treatmentfocusing On Its Proprietary Productpelareorepthis Oncolytic Reovirus Is Designed To Activate The Immune System Against Tumors And Is Administered Intravenouslyallowing For Broad Antitumor Activity Across Various Cancer Types Pelareorep Selectively Replicates In Cancer Cellstriggering Immune Responses That Can Transformcoldtumors Intohottumorsmaking Them More Susceptible To Other Treatmentsoncolytics Is Currently Conducting Clinical Trials For Pelareorep In Hrher2Metastatic Breast Cancer And Metastatic Pancreatic Ductal Adenocarcinomawith Promising Early Data Indicating Potential Survival Benefitsthe Company Collaborates With Academic Institutions And Pharmaceutical Partners To Enhance The Applications Of Pelareorepparticularly In Combination With Other Therapies
| Company Name | Oncolytics Biotech Inc |
| Country |
United States
|
| Address | N/A |
| Telephone | N/A |
| N/A |
